AAAAAA

   
Results: 1-11 |
Results: 11
A kinetic analysis of the tissue plasminogen activator and DSPA alpha 1 cofactor activities of untreated and TAFIa-treated soluble fibrin degradationproducts of varying size
Authors: Walker, JB Nesheim, ME
Citation: Jb. Walker et Me. Nesheim, A kinetic analysis of the tissue plasminogen activator and DSPA alpha 1 cofactor activities of untreated and TAFIa-treated soluble fibrin degradationproducts of varying size, J BIOL CHEM, 276(5), 2001, pp. 3138-3148
Channeling during prothrombin activation
Authors: Boskovic, DS Bajzar, LS Nesheim, ME
Citation: Ds. Boskovic et al., Channeling during prothrombin activation, J BIOL CHEM, 276(31), 2001, pp. 28686-28693
The use of prothrombin(S525C) labeled with fluorescein to directly study the inhibition of prothrombinase by antithrombin during prothrombin activation
Authors: Brufatto, N Nesheim, ME
Citation: N. Brufatto et Me. Nesheim, The use of prothrombin(S525C) labeled with fluorescein to directly study the inhibition of prothrombinase by antithrombin during prothrombin activation, J BIOL CHEM, 276(21), 2001, pp. 17663-17671
Association of a single nucleotide polymorphism in CPB2 encoding the thrombin-activable fibrinolysis inhibitor (TAFI) with blood pressure
Authors: Koschinsky, ML Boffa, MB Nesheim, ME Zinman, B Hanley, AJG Harris, SB Cao, H Hegele, RA
Citation: Ml. Koschinsky et al., Association of a single nucleotide polymorphism in CPB2 encoding the thrombin-activable fibrinolysis inhibitor (TAFI) with blood pressure, CLIN GENET, 60(5), 2001, pp. 345-349
A novel, possibly functional, single nucleotide polymorphism in the codingregion of the thrombin-activatable fibrinolysis inhibitor (TAFI) gene is also associated with TAFI levels
Authors: Brouwers, GJ Vos, HL Leebeek, FWG Bulk, S Schneider, M Boffa, M Koschinsky, M van Tilburg, NH Nesheim, ME Bertina, RM Garcia, EBG
Citation: Gj. Brouwers et al., A novel, possibly functional, single nucleotide polymorphism in the codingregion of the thrombin-activatable fibrinolysis inhibitor (TAFI) gene is also associated with TAFI levels, BLOOD, 98(6), 2001, pp. 1992-1993
Fluorescence properties and functional roles of tryptophan residues 60d, 96, 148, 207, and 215 of thrombin
Authors: Bell, R Stevens, WK Jia, ZC Samis, J Cote, HCF MacGillivray, RTA Nesheim, ME
Citation: R. Bell et al., Fluorescence properties and functional roles of tryptophan residues 60d, 96, 148, 207, and 215 of thrombin, J BIOL CHEM, 275(38), 2000, pp. 29513-29520
Roles of thermal instability and proteolytic cleavage in regulation of activated thrombin-activable fibrinolysis inhibitor
Authors: Boffa, MB Bell, R Stevens, WK Nesheim, ME
Citation: Mb. Boffa et al., Roles of thermal instability and proteolytic cleavage in regulation of activated thrombin-activable fibrinolysis inhibitor, J BIOL CHEM, 275(17), 2000, pp. 12868-12878
Proteolytic processing of human coagulation factor IX by plasmin
Authors: Samis, JA Ramsey, GD Walker, JB Nesheim, ME Giles, AR
Citation: Ja. Samis et al., Proteolytic processing of human coagulation factor IX by plasmin, BLOOD, 95(3), 2000, pp. 943-951
TAFI
Authors: Nesheim, ME
Citation: Me. Nesheim, TAFI, FIBRINOL PR, 13(2), 1999, pp. 72-77
The molecular weights, mass distribution, chain composition, and structureof soluble fibrin degradation products released from a fibrin clot perfused with plasmin
Authors: Walker, JB Nesheim, ME
Citation: Jb. Walker et Me. Nesheim, The molecular weights, mass distribution, chain composition, and structureof soluble fibrin degradation products released from a fibrin clot perfused with plasmin, J BIOL CHEM, 274(8), 1999, pp. 5201-5212
Characterization of the gene encoding human TAFI (thrombin-activable fibrinolysis inhibitor; plasma procarboxypeptidase B)
Authors: Boffa, MB Reid, TS Joo, E Nesheim, ME Koschinsky, ML
Citation: Mb. Boffa et al., Characterization of the gene encoding human TAFI (thrombin-activable fibrinolysis inhibitor; plasma procarboxypeptidase B), BIOCHEM, 38(20), 1999, pp. 6547-6558
Risultati: 1-11 |